BRAF and melanoma: To test the sensitivity of Pex3+/– melanomas to BRAF inhibition in vivo, we next injected D4M.3a Cas9-Ctrl, Pex3+/– clone 6D, or Pex3+/– clone 9G cells into syngeneic mice.